Counterparty Due Diligence | SwissMed Investments<\/title>\n<style>\n.cd-page{--ink:#1d2b3a;--deep:#15263a;--paper:#f8f8f5;--soft:#eef1ef;--line:#d6ddd9;--accent:#4f7777;--accent2:#b59a6b;--blue:#6d8790;--muted:#69747b;--white:#fff}\n.cd-page *{box-sizing:border-box}.cd-page{scroll-behavior:smooth}.cd-page{margin:0;background:var(--paper);color:var(--ink);font-family:Arial,Helvetica,sans-serif;line-height:1.65}.cd-page a{text-decoration:none;color:inherit}\n.cd-page{overflow:hidden}.cd-page .wrap{width:min(1180px,calc(100% - 56px));margin:auto}\n.cd-page .hero{background:linear-gradient(125deg,#15263a 0%,#1d3547 55%,#365f63 100%);color:#fff;padding:105px 0 74px;position:relative}\n.cd-page .hero:after{content:\"\";position:absolute;inset:0;background:radial-gradient(circle at 82% 18%,rgba(181,154,107,.18),transparent 34%);pointer-events:none}\n.cd-page .hero-inner{position:relative;z-index:1}.cd-page .hero-kicker{font-size:12px;letter-spacing:.24em;text-transform:uppercase;color:#c8d5d4;margin-bottom:24px}\n.cd-page h1{font-size:clamp(2.45rem,5.2vw,5.35rem);line-height:.94;letter-spacing:-.055em;margin:0;max-width:930px;word-break:keep-all;overflow-wrap:normal}\n.cd-page h1{color:#fff !important}.cd-page h1 span{color:#b59a6b !important}.cd-page .elementor .hero h1, .cd-page .elementor-widget-html .hero h1{font-size:clamp(2.45rem,5.2vw,5.35rem) !important;line-height:.94 !important;letter-spacing:-.055em !important}.cd-page .elementor .hero h1 span, .cd-page .elementor-widget-html .hero h1 span{font-size:inherit !important;color:#b59a6b !important}.cd-page .hero-sub{font-size:16px;letter-spacing:.19em;text-transform:uppercase;color:#dbe3e2;margin-top:28px}\n.cd-page .hero-meta{display:flex;flex-wrap:wrap;gap:12px 28px;margin-top:34px;font-size:12px;letter-spacing:.13em;text-transform:uppercase;color:#c7d1d0}\n.cd-page .brochure{display:inline-flex;align-items:center;justify-content:center;margin-top:30px;padding:15px 25px;background:#4f7777;border:1px solid #b59a6b;color:#fff;border-radius:2px;font-size:12px;letter-spacing:.15em;text-transform:uppercase;box-shadow:0 10px 28px rgba(0,0,0,.18);transition:.25s ease}\n.cd-page .brochure:hover{background:#628b8b;transform:translateY(-2px);box-shadow:0 14px 34px rgba(0,0,0,.24)}\n.cd-page .intro-block{padding:74px 0 22px}.cd-page .section-label{font-size:11px;letter-spacing:.24em;text-transform:uppercase;color:var(--accent);font-weight:700;margin-bottom:18px}\n.cd-page .lead{font-size:clamp(20px,2.3vw,29px);line-height:1.45;max-width:920px;color:#2c3c47;margin:0}\n .cd-page .question-grid{display:grid;grid-template-columns:repeat(5,1fr);gap:14px;margin-top:34px;background:transparent;border:0}\n.cd-page .question-grid div{position:relative;background:#fff;padding:27px 21px 24px;min-height:148px;border:1px solid #d8dfdc;border-top:3px solid #6d8790;box-shadow:0 7px 20px rgba(29,43,58,.055);transition:transform .2s ease,box-shadow .2s ease}\n.cd-page .question-grid div:nth-child(2){border-top-color:#b59a6b;background:#fbfaf7}.cd-page .question-grid div:nth-child(3){border-top-color:#4f7777;background:#f7faf9}.cd-page .question-grid div:nth-child(4){border-top-color:#8a9aa1;background:#f8fafb}.cd-page .question-grid div:nth-child(5){border-top-color:#b59a6b;background:#fbfaf7}\n.cd-page .question-grid div:before{content:\"\";position:absolute;left:21px;top:18px;width:24px;height:1px;background:#b59a6b}\n.cd-page .question-grid b{display:block;color:#1d3547;font-size:10px;letter-spacing:.16em;margin:10px 0 15px;font-weight:600}.cd-page .question-grid span{font-size:15px;line-height:1.45;color:#34434c}\n@media(min-width:901px){.cd-page .question-grid div:hover{transform:translateY(-3px);box-shadow:0 11px 25px rgba(29,43,58,.09)}}\n.cd-page .content{padding:30px 0 90px}.cd-page .section-card{display:grid;grid-template-columns:92px 1fr;gap:30px;border-top:1px solid var(--line);padding:62px 0}\n.cd-page .section-no{font-size:13px;letter-spacing:.18em;color:var(--accent2);padding-top:8px;font-weight:700}.cd-page h2{font-size:clamp(25px,3vw,39px);line-height:1.12;letter-spacing:-.025em;font-weight:500;margin:0 0 16px;color:var(--deep)}\n.cd-page .section-content .intro{max-width:920px;margin:0 0 24px;font-size:17px;color:#4e5b61}.cd-page .eyebrow{font-size:10px;letter-spacing:.2em;text-transform:uppercase;color:var(--accent);font-weight:700;margin:28px 0 13px}\n.cd-page .checklist{display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:0 28px;padding:0;margin:0;list-style:none;max-width:1000px}\n.cd-page .checklist li{position:relative;padding:10px 0 10px 22px;border-bottom:1px solid #e5e8e5;font-size:15px;color:#33434b}\n.cd-page .checklist li:before{content:\"\";position:absolute;left:0;top:18px;width:6px;height:6px;border-radius:50%;background:var(--accent2)}\n.cd-page .highlight{font-size:20px;line-height:1.5;color:var(--deep);margin:12px 0;max-width:1000px}\n.cd-page .note{font-size:14px;color:#657177;max-width:980px;margin:25px 0 0}\n.cd-page .deliverable-grid{display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:1px;background:var(--line);border:1px solid var(--line);margin-top:28px}\n.cd-page .deliverable-grid div{background:#fff;padding:23px 24px;min-height:110px}.cd-page .deliverable-grid b{display:block;color:var(--accent);font-size:12px;letter-spacing:.08em;margin-bottom:8px}.cd-page .deliverable-grid span{font-size:14px;color:#56636a}\n.cd-page .matrix-title{margin:42px 0 14px;font-size:11px;letter-spacing:.22em;text-transform:uppercase;color:var(--accent);font-weight:700}\n.cd-page .matrix{width:100%;border-collapse:collapse;background:#fff;border:1px solid var(--line);font-size:14px}.cd-page .matrix th, .cd-page .matrix td{padding:15px 17px;border-bottom:1px solid var(--line);text-align:left;vertical-align:top}.cd-page .matrix th{background:var(--soft);color:var(--deep);font-size:10px;letter-spacing:.16em;text-transform:uppercase}.cd-page .matrix td:first-child{width:36%;font-weight:600;color:#33444c}\n.cd-page .principle{margin-top:25px;background:linear-gradient(135deg,#15263a,#23464f);color:#fff;padding:70px 8%;position:relative;overflow:hidden}.cd-page .principle:after{content:\"\";position:absolute;width:320px;height:320px;border:1px solid rgba(181,154,107,.3);border-radius:50%;right:-110px;top:-110px}\n.cd-page .principle .section-label{color:#b59a6b}.cd-page .principle h2{color:#fff;max-width:850px;font-size:clamp(28px,4vw,48px)}\n.cd-page .principle h2{font-family:Arial,Helvetica,sans-serif !important;}.cd-page .principle .principle-lines{font-size:18px;letter-spacing:.11em;text-transform:uppercase;color:#dce6e4;line-height:2;position:relative;z-index:1}.cd-page .principle p{max-width:880px;color:#d0dbda;position:relative;z-index:1}\n@media(max-width:900px){.cd-page .wrap{width:min(100% - 38px,720px)}.cd-page .question-grid{grid-template-columns:repeat(2,1fr)}.cd-page .question-grid div:last-child{grid-column:1\/-1}.cd-page .section-card{grid-template-columns:62px 1fr;gap:18px}.cd-page .deliverable-grid{grid-template-columns:1fr}}\n@media(max-width:640px){.cd-page .wrap{width:calc(100% - 30px)}.cd-page .hero{padding:70px 0 54px}.cd-page h1{font-size:39px !important;line-height:1.06;letter-spacing:-.035em}.cd-page .hero-sub{font-size:12px;line-height:1.6;letter-spacing:.12em}.cd-page .hero-meta{gap:9px 18px;font-size:10px}.cd-page .brochure{width:100%;margin-top:26px}.cd-page .intro-block{padding:52px 0 12px}.cd-page .lead{font-size:20px}.cd-page .question-grid{grid-template-columns:1fr}.cd-page .question-grid div:last-child{grid-column:auto}.cd-page .section-card{grid-template-columns:1fr;gap:8px;padding:45px 0}.cd-page .section-no{padding:0}.cd-page h2{font-size:29px}.cd-page .section-content .intro{font-size:16px}.cd-page .checklist{grid-template-columns:1fr}.cd-page .checklist li{font-size:14px}.cd-page .highlight{font-size:17px}.cd-page .matrix{font-size:12px}.cd-page .matrix th, .cd-page .matrix td{padding:11px 10px}.cd-page .matrix td:first-child{width:40%}.cd-page .principle{padding:52px 28px}.cd-page .principle .principle-lines{font-size:14px;letter-spacing:.07em}}\n\n\/* v33 targeted refinements *\/\n.cd-page .section-card .section-heading h2{color:#B59A6B !important;}\n.cd-page .section-content .objective-lead{margin-top:25px !important;margin-bottom:8px !important;}\n.cd-page .section-content .objective-line{margin:0 !important;line-height:1.45 !important;}\n.cd-page .section-content .objective-and{margin:2px 0 !important;line-height:1.35 !important;}\n<\/style>\n\n\n\n\n\n\n\n\n\n\n\n\n<style id=\"VISIBLE-TWO-BACKGROUNDS\">\n.cd-page main.content .section-card{\n position:relative;\n isolation:isolate;\n z-index:0;\n}\n.cd-page main.content .section-card::before{\n content:\"\";\n position:absolute;\n z-index:-1;\n top:0;\n bottom:0;\n left:50%;\n width:100vw;\n transform:translateX(-50%);\n background:#F4F5F3 !important;\n}\n.cd-page main.content .section-card:nth-of-type(even)::before{\n background:#E8F0F3 !important;\n}\n\/* Keep the closing THE PRINCIPLE section untouched. *\/\n<\/style>\n\n\n<style id=\"MINIMAL-CARD-REFINEMENT\">\n\/* Minimal card refinement *\/\n.cd-page .section-card .checklist{\n gap:0 30px;\n}\n.cd-page .section-card .checklist li{\n padding:9px 0 9px 20px;\n border-bottom:1px solid rgba(79,119,119,.14);\n}\n.cd-page .section-card .checklist li:before{\n width:5px;\n height:5px;\n top:17px;\n background:#B59A6B;\n}\n.cd-page .section-card .eyebrow{\n color:#4F7777;\n position:relative;\n padding-bottom:8px;\n}\n.cd-page .section-card .eyebrow:after{\n content:\"\";\n display:block;\n width:34px;\n height:1px;\n margin-top:7px;\n background:#B59A6B;\n}\n.cd-page .section-card .note:first-of-type{\n color:#4F7777;\n letter-spacing:.12em;\n text-transform:uppercase;\n font-size:10px;\n font-weight:700;\n}\n\n\/* Make the existing deliverable matrix\/cards feel more like restrained information panels *\/\n.cd-page .deliverable-grid{\n background:rgba(214,221,217,.65);\n border-color:rgba(214,221,217,.65);\n gap:1px;\n}\n.cd-page .deliverable-grid div{\n background:rgba(255,255,255,.72);\n padding:20px 22px;\n}\n.cd-page .deliverable-grid b{\n color:#1D2B3A;\n}\n.cd-page .matrix{\n background:rgba(255,255,255,.78);\n}\n.cd-page .matrix th{\n background:rgba(232,240,243,.72);\n}\n\n\/* Subtle emphasis for important inline findings *\/\n.cd-page .highlight{\n border-left:2px solid #B59A6B;\n padding-left:16px;\n}\n\n\/* Keep the design spacious rather than over-decorated *\/\n.cd-page .section-card{\n padding:58px 0;\n}\n<\/style>\n\n\n<style id=\"COLORFUL-CARDS-ONLY\">\n\/* Only the internal cards get color; the v13 layout remains unchanged. *\/\n.cd-page .deliverable-grid div:nth-child(3n\/**\/+1){\n background:#E8F0F3 !important;\n}\n.cd-page .deliverable-grid div:nth-child(3n\/**\/+2){\n background:#F3EEE5 !important;\n}\n.cd-page .deliverable-grid div:nth-child(3n){\n background:#EAF1EF !important;\n}\n\n.cd-page .matrix th{\n background:#E8F0F3 !important;\n}\n.cd-page .matrix tbody tr:nth-child(odd) td{\n background:#F8F8F5 !important;\n}\n.cd-page .matrix tbody tr:nth-child(even) td{\n background:#EEF2F5 !important;\n}\n<\/style>\n\n\n<style id=\"DUE-DILIGENCE-MATRIX-REFINEMENT\">\n\/* Refine only the K. Verification Matrix inside DUE DILIGENCE DELIVERABLE *\/\n.cd-page .matrix-title{\n margin-top:44px !important;\n margin-bottom:16px !important;\n color:#4F7777 !important;\n position:relative;\n}\n.cd-page .matrix-title:after{\n content:\"\";\n display:block;\n width:42px;\n height:2px;\n margin-top:9px;\n background:#B59A6B;\n}\n.cd-page .matrix{\n border:1px solid #D6DDD9 !important;\n border-collapse:separate !important;\n border-spacing:0 !important;\n border-radius:4px !important;\n overflow:hidden !important;\n box-shadow:0 8px 22px rgba(29,43,58,.06);\n}\n.cd-page .matrix th{\n padding:16px 18px !important;\n background:#1D3547 !important;\n color:#fff !important;\n border-bottom:0 !important;\n font-size:10px !important;\n letter-spacing:.18em !important;\n}\n.cd-page .matrix th:first-child{\n width:36% !important;\n}\n.cd-page .matrix td{\n padding:15px 18px !important;\n border-bottom:1px solid #DDE3E0 !important;\n color:#40505A !important;\n background:#F8F8F5 !important;\n}\n.cd-page .matrix tbody tr:nth-child(even) td{\n background:#E8F0F3 !important;\n}\n.cd-page .matrix tbody tr:last-child td{\n border-bottom:0 !important;\n}\n.cd-page .matrix td:first-child{\n color:#1D2B3A !important;\n font-weight:600 !important;\n letter-spacing:.01em;\n}\n.cd-page .matrix td:nth-child(2){\n color:#596970 !important;\n}\n<\/style>\n\n\n<style id=\"DELIVERABLE-GRID-PREMIUM\">\n\/* Refine only the A\u2013J deliverable cards above the Verification Matrix *\/\n.cd-page .deliverable-grid{\n gap:0 !important;\n background:#D9E1DE !important;\n border:1px solid #D2DCD8 !important;\n border-radius:5px !important;\n overflow:hidden !important;\n box-shadow:0 8px 24px rgba(29,43,58,.055) !important;\n}\n.cd-page .deliverable-grid div{\n position:relative;\n background:#FAFAF7 !important;\n padding:24px 25px 23px 27px !important;\n min-height:118px !important;\n border:0 !important;\n}\n.cd-page .deliverable-grid div:nth-child(4n\/**\/+1), .cd-page .deliverable-grid div:nth-child(4n\/**\/+4){\n background:#F4F5F3 !important;\n}\n.cd-page .deliverable-grid div:nth-child(4n\/**\/+2){\n background:#EAF1F1 !important;\n}\n.cd-page .deliverable-grid div:nth-child(4n\/**\/+3){\n background:#F3EEE5 !important;\n}\n.cd-page .deliverable-grid div:before{\n content:\"\";\n position:absolute;\n left:0;\n top:0;\n bottom:0;\n width:3px;\n background:#4F7777;\n}\n.cd-page .deliverable-grid div:nth-child(3n):before{\n background:#B59A6B;\n}\n.cd-page .deliverable-grid b{\n margin-bottom:9px !important;\n color:#1D3547 !important;\n font-size:10px !important;\n letter-spacing:.13em !important;\n line-height:1.45 !important;\n}\n.cd-page .deliverable-grid span{\n display:block;\n font-size:13px !important;\n line-height:1.65 !important;\n color:#596970 !important;\n max-width:48ch;\n}\n@media(max-width:900px){\n .cd-page .deliverable-grid div{padding:22px 23px 21px 25px !important;}\n}\n@media(max-width:640px){\n .cd-page .deliverable-grid div{padding:21px 20px 20px 23px !important;min-height:0 !important;}\n .cd-page .deliverable-grid b{font-size:10px !important;}\n .cd-page .deliverable-grid span{font-size:13px !important;}\n}\n<\/style>\n\n<style id=\"THE-PRINCIPLE-COLOR-REFINEMENT\">\n.cd-page .principle{\n background:linear-gradient(135deg,#142B3B 0%,#1E4650 58%,#315F61 100%) !important;\n}\n.cd-page .principle:after{\n width:360px !important;height:360px !important;\n border:1px solid rgba(181,154,107,.34) !important;\n box-shadow:0 0 0 70px rgba(181,154,107,.035);\n}\n.cd-page .principle .section-label{\n color:#C9A96E !important;\n letter-spacing:.27em;\n}\n.cd-page .principle h2{\n color:#F7F8F5 !important;\n}\n.cd-page .principle h2 br{\n \/* retain exact line breaks *\/\n}\n.cd-page .principle .principle-lines{\n color:#E2ECEA !important;\n border-left:2px solid #B59A6B;\n padding-left:20px;\n margin:25px 0;\n}\n.cd-page .principle p{\n color:#D0DEDC !important;\n}\n<\/style>\n\n<style id=\"BROCHURE-HOVER-FIX\">\n.cd-page .brochure:hover{\n background:#4f7777 !important;\n color:#ffffff !important;\n border-color:#b59a6b !important;\n transform:none !important;\n box-shadow:0 10px 28px rgba(0,0,0,.18) !important;\n}\n.cd-page .brochure:focus, .cd-page .brochure:active{\n color:#ffffff !important;\n}\n<\/style>\n<style id=\"SECTION-HEADINGS-LEFT\">.cd-page .section-card{grid-template-columns:300px 1fr !important;gap:28px !important;align-items:start}.cd-page .section-heading{display:flex;align-items:flex-start;gap:18px;padding-top:7px;transform:translateY(-4px)}.cd-page .section-heading .section-no{flex:0 0 auto;padding-top:0;font-size:13px;letter-spacing:.18em;color:#B59A6B;font-weight:700}.cd-page .section-heading h2{transform:none;margin:0!important;color:#B59A6B!important;font-size:13px!important;line-height:1.45!important;letter-spacing:.16em!important;font-weight:700!important;text-transform:uppercase!important}@media(max-width:900px){.cd-page .section-card{grid-template-columns:1fr!important;gap:10px!important}.cd-page .section-heading{padding-top:0;gap:15px;transform:none}.cd-page .section-heading h2{font-size:13px!important}}@media(max-width:640px){.cd-page .section-heading{gap:12px}.cd-page .section-heading .section-no{font-size:12px}.cd-page .section-heading h2{font-size:12px!important;line-height:1.5!important}}<\/style>\n<style>\n\/* v31 \u2014 Section 05: tighter evidence lines *\/\n.cd-page .section-card:nth-of-type(5) .section-content strong{\n font-weight: 700;\n}\n.cd-page .section-card:nth-of-type(5) .section-content p{\n margin-bottom: 10px !important;\n}\n.cd-page .section-card:nth-of-type(5) .section-content p + p{\n margin-top: 4px !important;\n}\n<\/style>\n\n<style>\n\/* v32 \u2014 Section 05: tighter spacing around \u201cand\u201d *\/\n.cd-page .section-card:nth-of-type(5) .section-content p:nth-of-type(3){\n margin-bottom: 2px !important;\n}\n.cd-page .section-card:nth-of-type(5) .section-content p:nth-of-type(4){\n margin-top: 0 !important;\n margin-bottom: 0 !important;\n line-height: 1.2 !important;\n}\n.cd-page .section-card:nth-of-type(5) .section-content p:nth-of-type(5){\n margin-top: 2px !important;\n}\n<\/style>\n\n<style id=\"v34-fixes\">\n\/* v34 \u2014 equal spacing around \u201cand\u201d + section 14\/15 heading alignment *\/\n.cd-page .section-card:nth-of-type(5) .section-content .objective-line{\n margin: 2px 0 !important;\n line-height: 1.45 !important;\n}\n.cd-page .section-card:nth-of-type(5) .section-content .objective-and{\n margin: 2px 0 !important;\n line-height: 1.2 !important;\n}\n.cd-page .section-card:nth-of-type(5) .section-content .objective-lead{\n margin-bottom: 4px !important;\n}\n<\/style>\n<\/head>\n<body>\n<div class=\"cd-page\">\n<header class=\"hero\"><div class=\"wrap hero-inner\">\n<div class=\"hero-kicker\"><\/div>\n<h1>COUNTERPARTY<br><span>DUE DILIGENCE<\/span><\/h1>\n<div class=\"hero-sub\">EXACT SCOPE OF REVIEW<\/div>\n<div class=\"hero-meta\"><span>Evidence-Based Review<\/span><span>Corporate Standing<\/span><span>Commercial Representation<\/span><span>Risk Indicators<\/span><\/div>\n<a class=\"brochure\" href=\"https:\/\/swissmedinvestments.com\/wp-content\/uploads\/2026\/09\/brochure-COUNTERPARTY-DUE-DILIGENCE.pdf\" target=\"_blank\" rel=\"noopener\">COUNTERPARTY DUE DILIGENCE PDF \u2192<\/a>\n<\/div><\/header>\n<section class=\"intro-block\"><div class=\"wrap\">\n<div class=\"section-label\">EXACT SCOPE OF REVIEW<\/div>\n<p class=\"lead\">Our Counterparty Due Diligence is a structured, evidence-based review of the identity, corporate standing, commercial representation and relevant risk indicators associated with a prospective supplier, seller, trading entity or authorized representative.<\/p>\n<p style=\"margin:24px 0 0;color:#59666c;font-size:16px\">The scope is designed to answer five fundamental questions:<\/p>\n<div class=\"question-grid\">\n<div><b>01<\/b><span>WHO IS THE COUNTERPARTY?<\/span><\/div>\n<div><b>02<\/b><span>WHO OWNS AND CONTROLS THE ENTITY?<\/span><\/div>\n<div><b>03<\/b><span>WHAT IS THE COUNTERPARTY REPRESENTING?<\/span><\/div>\n<div><b>04<\/b><span>WHAT CAN BE INDEPENDENTLY VERIFIED?<\/span><\/div>\n<div><b>05<\/b><span>WHAT MATERIAL RED FLAGS OR INFORMATION GAPS EXIST?<\/span><\/div>\n<\/div>\n<\/div><\/section>\n<main class=\"content\"><div class=\"wrap\">\n<section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">01<\/div><h2>CORPORATE IDENTITY & EXISTENCE<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Verification and review of the legal identity of the proposed counterparty.<\/p><div class=\"eyebrow\">Scope includes:<\/div><ul class=\"checklist\"><li>Full legal entity name<\/li><li>Trading name \/ commercial name<\/li><li>Registration number<\/li><li>Date of incorporation<\/li><li>Registered jurisdiction<\/li><li>Registered office<\/li><li>Current corporate status<\/li><li>Nature of business<\/li><li>Available corporate filings<\/li><li>Official corporate registry information<\/li><li>Identification of relevant subsidiaries or affiliated entities, where identifiable<\/li><\/ul><p class=\"note\">Objective<\/p><p class=\"note\">To establish that the entity exists, is identifiable and corresponds to the entity presented in the commercial proposition.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">02<\/div><h2>OWNERSHIP & CONTROL<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Assessment of the available information concerning ownership and control.<\/p><div class=\"eyebrow\">Scope includes:<\/div><ul class=\"checklist\"><li>Shareholding structure<\/li><li>Ultimate Beneficial Owner (UBO), where publicly identifiable or appropriately documented<\/li><li>Directors<\/li><li>Officers<\/li><li>Authorized representatives<\/li><li>Parent companies<\/li><li>Affiliates<\/li><li>Related entities<\/li><li>Changes in ownership or management, where relevant and available<\/li><\/ul><p class=\"note\">Objective<\/p><p class=\"note\">To establish who ultimately owns, controls or represents the entity, and whether the individuals presented to the buyer appear to have the authority they claim.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">03<\/div><h2>REPRESENTATION & MANDATE VERIFICATION<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Where a party claims to act on behalf of a producer, refinery, trading company, supplier or other principal, the representation itself becomes a critical part of the review.<\/p><div class=\"eyebrow\">Scope includes:<\/div><ul class=\"checklist\"><li>Identity of the claimed principal<\/li><li>Identity of the representative<\/li><li>Claimed relationship with the principal<\/li><li>Nature and scope of the mandate<\/li><li>Validity period, where available<\/li><li>Consistency between the representative's claims and available corporate information<\/li><li>Supporting authorization or mandate documentation, where provided<\/li><li>Verification of the relationship through independent channels where reasonably possible<\/li><\/ul><p class=\"note\">Objective<\/p><p class=\"note\">To distinguish between:<\/p><p class=\"note\">Direct Principal \u2192 Authorized Representative \u2192 Independent Intermediary \u2192 Unverified Claim of Representation<\/p><p class=\"note\">No mandate is treated as verified solely because a document has been presented.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">04<\/div><h2>MANAGEMENT & KEY PERSONNEL<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Review of individuals materially involved in the proposed transaction.<\/p><div class=\"eyebrow\">Scope includes:<\/div><ul class=\"checklist\"><li>Directors<\/li><li>Senior management<\/li><li>Authorized signatories<\/li><li>Commercial representatives<\/li><li>Beneficial owners, where identifiable<\/li><li>Relevant professional \/ corporate affiliations<\/li><li>Publicly available professional information<\/li><\/ul><p class=\"note\">Review focus:<\/p><ul class=\"checklist\"><li>Identity consistency<\/li><li>Corporate association<\/li><li>Role and authority<\/li><li>Relevant public information<\/li><li>Potential adverse indicators<\/li><\/ul><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">05<\/div><h2>COMMERCIAL PROFILE<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Assessment of whether the counterparty's stated business profile is broadly consistent with the proposed transaction.<\/p><div class=\"eyebrow\">Scope includes:<\/div><ul class=\"checklist\"><li>Stated business activities<\/li><li>Trading profile<\/li><li>Product categories<\/li><li>Geographic footprint<\/li><li>Claimed market position<\/li><li>Historical activity, where independently available<\/li><li>Relevant counterparties or commercial relationships, where publicly verifiable<\/li><li>Stated supply capability<\/li><li>Proposed transaction structure<\/li><\/ul><p class=\"note\">Objective<\/p><p class=\"note objective-lead\">To identify material discrepancies between:<\/p><p class=\"note objective-line\"><strong>What the entity claims to do<\/strong><\/p><p class=\"note objective-and\">and<\/p><p class=\"note objective-line\"><strong>What available evidence indicates it actually does.<\/strong><\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">06<\/div><h2>PRODUCT & SUPPLY CLAIMS<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Review of the information supporting the proposed supply opportunity.<\/p><div class=\"eyebrow\">Scope may include:<\/div><ul class=\"checklist\"><li>Product name<\/li><li>Product specification<\/li><li>Origin<\/li><li>Indicative quantity<\/li><li>Availability period<\/li><li>Loading point<\/li><li>Terminal \/ refinery information, where applicable<\/li><li>Delivery structure<\/li><li>Proposed Incoterms<\/li><li>Pricing structure<\/li><li>Allocation \/ availability claims<\/li><li>Supporting commercial documentation<\/li><\/ul><p class=\"note\">Objective<\/p><p class=\"note\">To determine whether the commercial proposition is internally consistent and sufficiently documented to justify further investigation.<\/p><p class=\"note\">This review does not constitute physical inspection, title verification, inventory certification or confirmation of actual product availability unless separately mandated and independently performed by the appropriate parties.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">07<\/div><h2>DOCUMENT AUTHENTICITY & CONSISTENCY REVIEW<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Review of documents supplied during the engagement.<\/p><div class=\"eyebrow\">Documents may include:<\/div><ul class=\"checklist\"><li>Certificates of incorporation<\/li><li>Corporate extracts<\/li><li>Licenses<\/li><li>Certificates<\/li><li>Company profiles<\/li><li>Mandates<\/li><li>Letters of authorization<\/li><li>Commercial offers<\/li><li>Product specifications<\/li><li>Invoices<\/li><li>Contracts \/ draft contracts<\/li><li>Logistics documentation<\/li><li>Other transaction-related materials<\/li><\/ul><p class=\"note\">Review focuses on:<\/p><ul class=\"checklist\"><li>Internal consistency<\/li><li>Entity names<\/li><li>Dates<\/li><li>Registration information<\/li><li>Signatories<\/li><li>Corporate details<\/li><li>Contact information<\/li><li>Formatting and structural inconsistencies<\/li><li>Cross-reference against independently available information<\/li><\/ul><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">08<\/div><h2>SANCTIONS & RESTRICTED-PARTY SCREENING<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Screening of the relevant entities and individuals against applicable publicly available sanctions and restricted-party information.<\/p><div class=\"eyebrow\">Screening may cover:<\/div><ul class=\"checklist\"><li>Legal entity<\/li><li>Parent \/ affiliated entities<\/li><li>Directors<\/li><li>Beneficial owners, where identifiable<\/li><li>Key representatives<\/li><li>Relevant transaction parties<\/li><\/ul><p class=\"note\">Potential areas include:<\/p><ul class=\"checklist\"><li>Sanctions lists<\/li><li>Restricted-party lists<\/li><li>Government enforcement information<\/li><li>Regulatory actions<\/li><li>Export-control related restrictions<\/li><\/ul><p class=\"note\">The applicable screening scope depends on the jurisdictions, entities, individuals and transaction structure involved.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">09<\/div><h2>ADVERSE MEDIA & REPUTATIONAL SCREENING<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Review of credible publicly available information for material adverse indicators.<\/p><div class=\"eyebrow\">Search areas may include:<\/div><ul class=\"checklist\"><li>Fraud allegations<\/li><li>Financial crime allegations<\/li><li>Corruption-related matters<\/li><li>Sanctions \/ regulatory issues<\/li><li>Litigation of material relevance<\/li><li>Enforcement actions<\/li><li>Misrepresentation allegations<\/li><li>Corporate misconduct<\/li><li>Significant commercial disputes<\/li><\/ul><p class=\"note\">Findings are distinguished between:<\/p><p class=\"note\">Verified Facts | Official Proceedings | Reported Allegations | Unsubstantiated Claims<\/p><p class=\"note\">No adverse-media finding is treated as established fact solely because it has been reported publicly.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">10<\/div><h2>LITIGATION & REGULATORY REVIEW<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Where reliable public information is available, review may include:<\/p><ul class=\"checklist\"><li>Material litigation<\/li><li>Regulatory proceedings<\/li><li>Government enforcement actions<\/li><li>Insolvency \/ bankruptcy indicators<\/li><li>Corporate disputes<\/li><li>Relevant judgments or official decisions<\/li><\/ul><p class=\"note\">The availability and completeness of such information varies significantly by jurisdiction.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">11<\/div><h2>DIGITAL & CONTACT VERIFICATION<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Assessment of the consistency of publicly presented contact and digital information.<\/p><div class=\"eyebrow\">May include:<\/div><ul class=\"checklist\"><li>Corporate website<\/li><li>Corporate domain<\/li><li>Official email domain<\/li><li>Published telephone information<\/li><li>Physical address<\/li><li>Public corporate profiles<\/li><li>Digital presence<\/li><li>Consistency between online and corporate information<\/li><\/ul><p class=\"note\">Particular attention is given to discrepancies between:<\/p><p class=\"note\">Corporate Identity \u2192 Domain \u2192 Email \u2192 Address \u2192 Personnel \u2192 Commercial Documentation<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">12<\/div><h2>RED-FLAG ANALYSIS<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">All material findings are evaluated for potential indicators requiring further investigation.<\/p><div class=\"eyebrow\">Examples include:<\/div><ul class=\"checklist\"><li>Inconsistent corporate information<\/li><li>Unclear ownership<\/li><li>Unverifiable representation<\/li><li>Conflicting company addresses<\/li><li>Inconsistent domains or email addresses<\/li><li>Unsupported supply claims<\/li><li>Unusual documentation<\/li><li>Material gaps in corporate information<\/li><li>Sanctions-related indicators<\/li><li>Significant adverse regulatory information<\/li><li>Unexplained changes in corporate identity<\/li><li>Pressure to bypass normal verification procedures<\/li><\/ul><p class=\"note\">A red flag is an indicator requiring investigation, not automatically proof of misconduct.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">13<\/div><h2>INFORMATION GAP ANALYSIS<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">A professional due diligence process should identify not only what is known, but also what cannot be established.<\/p><div class=\"eyebrow\">The review therefore identifies:<\/div><ul class=\"checklist\"><li>VERIFIED \u2014 Information supported by reliable evidence.<\/li><li>CORROBORATED \u2014 Information supported by more than one relevant source.<\/li><li>UNVERIFIED \u2014 Information for which adequate independent evidence has not been identified.<\/li><li>INCONSISTENT \u2014 Information that conflicts with available evidence.<\/li><li>OUTSTANDING \u2014 Information or documentation required for further assessment.<\/li><\/ul><p class=\"note\">This distinction is fundamental to the final assessment.<\/p><\/div><\/section>\n\n<section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">14<\/div><h2>DUE DILIGENCE DELIVERABLE<\/h2><\/div><div class=\"section-content\">\n<p class=\"intro\">Subject to the agreed engagement scope, the client receives a structured Counterparty Due Diligence Report containing:<\/p>\n<div class=\"deliverable-grid\">\n<div><b>A. Executive Summary<\/b><span>Concise overview of the counterparty and principal findings.<\/span><\/div>\n<div><b>B. Corporate Profile<\/b><span>Legal identity, jurisdiction, registration and corporate structure.<\/span><\/div>\n<div><b>C. Ownership & Management<\/b><span>Available ownership, UBO and management information.<\/span><\/div>\n<div><b>D. Representation<\/b><span>Assessment of the claimed mandate or commercial representation.<\/span><\/div>\n<div><b>E. Commercial Profile<\/b><span>Business activity and transaction-related information.<\/span><\/div>\n<div><b>F. Documentation Review<\/b><span>Summary of documents reviewed and material inconsistencies identified.<\/span><\/div>\n<div><b>G. Sanctions \/ Restricted-Party Screening<\/b><span>Screening results and relevant observations.<\/span><\/div>\n<div><b>H. Adverse Media<\/b><span>Material publicly available findings and source attribution.<\/span><\/div>\n<div><b>I. Litigation \/ Regulatory<\/b><span>Relevant publicly available proceedings or enforcement information.<\/span><\/div>\n<div><b>J. Red-Flag & Information-Gap Analysis<\/b><span>Outstanding issues requiring clarification or additional evidence.<\/span><\/div>\n<\/div>\n<div class=\"matrix-title\">K. Verification Matrix<\/div>\n<table class=\"matrix\"><thead><tr><th>Category<\/th><th>Status<\/th><\/tr><\/thead><tbody>\n<tr><td>Corporate Identity<\/td><td>Verified \/ Partially Verified \/ Unverified<\/td><\/tr>\n<tr><td>Ownership<\/td><td>Verified \/ Partially Verified \/ Unverified<\/td><\/tr>\n<tr><td>Management<\/td><td>Verified \/ Partially Verified \/ Unverified<\/td><\/tr>\n<tr><td>Representation<\/td><td>Verified \/ Partially Verified \/ Unverified<\/td><\/tr>\n<tr><td>Commercial Profile<\/td><td>Corroborated \/ Partially Corroborated \/ Unverified<\/td><\/tr>\n<tr><td>Documentation<\/td><td>Consistent \/ Inconsistent \/ Incomplete<\/td><\/tr>\n<tr><td>Sanctions Screening<\/td><td>No Relevant Match Identified \/ Potential Match \/ Requires Review<\/td><\/tr>\n<tr><td>Adverse Media<\/td><td>No Material Finding Identified \/ Finding \/ Requires Review<\/td><\/tr>\n<tr><td>Litigation \/ Regulatory<\/td><td>No Material Finding Identified \/ Finding \/ Requires Review<\/td><\/tr>\n<tr><td>Key Red Flags<\/td><td>Identified \/ None Identified \/ Further Review Required<\/td><\/tr>\n<tr><td>Outstanding Information<\/td><td>Listed in Report<\/td><\/tr>\n<\/tbody><\/table>\n<\/div><\/section>\n\n<section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">15<\/div><h2>SCOPE LIMITATIONS<\/h2><\/div><div class=\"section-content\">\n<p class=\"intro\">The due diligence service is a commercial and counterparty risk-screening exercise.<\/p>\n<p class=\"intro\">It does not, unless separately contracted and independently performed by appropriately qualified professionals, constitute:<\/p>\n<ul class=\"checklist\">\n<li>Legal due diligence<\/li><li>Audit<\/li><li>Financial statement verification<\/li><li>Credit rating<\/li><li>Banking verification<\/li><li>Regulatory certification<\/li><li>Sanctions clearance by a competent authority<\/li><li>Physical inspection of petroleum products<\/li><li>Verification of physical inventory<\/li><li>Title certification<\/li><li>Refinery confirmation<\/li><li>Terminal confirmation<\/li><li>Guarantee of product availability<\/li><li>Guarantee of transaction performance<\/li><li>Guarantee of counterparty solvency<\/li>\n<\/ul>\n<p class=\"note\">Where a matter requires specialist confirmation, the relevant legal, compliance, banking, inspection, logistics or other professional adviser should be engaged.<\/p>\n<\/div><\/section>\n<section class=\"principle\">\n<div class=\"section-label\">THE PRINCIPLE<\/div>\n<h2>VERIFY WHAT CAN BE VERIFIED.<br>IDENTIFY WHAT CANNOT.<br>FLAG WHAT REQUIRES FURTHER INVESTIGATION.<\/h2>\n<p>The purpose of the process is not to provide a superficial \u201capproved \/ rejected\u201d label.<\/p>\n<p>It is to give the client a structured understanding of:<\/p>\n<div class=\"principle-lines\">WHO THE COUNTERPARTY IS<br>WHAT THEY REPRESENT<br>WHAT CAN BE SUBSTANTIATED<br>WHAT REMAINS UNVERIFIED<br>WHAT POTENTIAL RED FLAGS EXIST<br>WHAT SHOULD BE CLARIFIED BEFORE FURTHER COMMERCIAL COMMITMENT<\/div>\n<p>This creates a more disciplined foundation for the next stage of the commercial relationship.<\/p>\n<\/section>\n<\/div><\/main>\n<\/div>\n\n<style>\n\/* v29: section headings match the section-number color; brochure button gets a lighter hover background *\/\n.cd-page .section-heading h2{color:#B59A6B!important;}\n.cd-page .brochure:hover, .cd-page .brochure:focus-visible{background:#6D9696!important;border-color:#B59A6B!important;color:#FFFFFF!important;}\n<\/style>\n\n\n\n<style id=\"ENERGY-EDITORIAL-ARCHITECTURE\">\n\/* Shared editorial section architecture \u2014 aligned with Independent Energy Supply *\/\n.cd-page main.content .section-card{\n display:grid !important;\n grid-template-columns:300px minmax(0,1fr) !important;\n gap:28px !important;\n align-items:start !important;\n border-top:1px solid var(--line) !important;\n padding:82px 0 !important;\n}\n.cd-page main.content .section-card .section-heading{\n display:flex !important;\n align-items:flex-start !important;\n gap:18px !important;\n padding:0 !important;\n margin:0 !important;\n transform:none !important;\n}\n.cd-page main.content .section-card .section-heading .section-no{\n flex:0 0 auto !important;\n padding:0 !important;\n margin:0 !important;\n font-size:13px !important;\n line-height:1.45 !important;\n letter-spacing:.18em !important;\n color:#B59A6B !important;\n font-weight:700 !important;\n}\n.cd-page main.content .section-card .section-heading h2{\n margin:0 !important;\n padding:0 !important;\n transform:none !important;\n color:#B59A6B !important;\n font-size:13px !important;\n line-height:1.45 !important;\n letter-spacing:.16em !important;\n font-weight:700 !important;\n text-transform:uppercase !important;\n}\n\/* The body starts slightly below the editorial heading, as on the Energy page. *\/\n.cd-page main.content .section-card .section-content{\n margin:0 !important;\n padding:15px 0 0 !important;\n min-width:0 !important;\n}\n.cd-page main.content .section-card .section-content .intro{\n margin-top:0 !important;\n}\n\/* Keep the Elementor hero typography controlled by the page itself. *\/\n.cd-page .elementor .hero h1, .cd-page .elementor-widget-html .hero h1{\n font-size:clamp(42px,7.2vw,96px) !important;\n}\n.cd-page .elementor .hero h1 span, .cd-page .elementor-widget-html .hero h1 span{\n font-size:inherit !important;\n}\n@media(max-width:900px){\n .cd-page main.content .section-card{\n grid-template-columns:1fr !important;\n gap:10px !important;\n padding:62px 0 !important;\n }\n .cd-page main.content .section-card .section-heading{\n gap:15px !important;\n transform:none !important;\n }\n .cd-page main.content .section-card .section-content{\n padding:8px 0 0 !important;\n }\n}\n@media(max-width:640px){\n .cd-page main.content .section-card{padding:45px 0 !important;}\n .cd-page main.content .section-card .section-heading{gap:12px !important;}\n .cd-page main.content .section-card .section-heading .section-no{font-size:12px !important;line-height:1.5 !important;}\n .cd-page main.content .section-card .section-heading h2{font-size:12px !important;line-height:1.5 !important;}\n}\n\n\/* Hero typography aligned with Independent Energy Supply Origination *\/\n.cd-page .hero h1{font-size:clamp(2.45rem,5.2vw,5.35rem) !important;line-height:.94 !important;letter-spacing:-.055em !important;max-width:930px !important;}\n.cd-page .hero h1 span{display:inline;color:#b59a6b !important;font-size:inherit !important;}\n@media(max-width:560px){.cd-page .hero h1{font-size:clamp(2rem,10vw,2.65rem) !important;line-height:.96 !important;letter-spacing:-.045em !important;word-break:keep-all !important;overflow-wrap:normal !important;hyphens:none !important;}}\n<\/style>\n\n<style id=\"DELIVERABLE-TYPOGRAPHY-ELEMENTOR\">\n\/* Final Elementor-safe typography for the A\u2013J Deliverable cards *\/\n.cd-page .deliverable-grid b{font-size:12px !important;line-height:1.35 !important;}\n.cd-page .deliverable-grid span{font-size:15px !important;line-height:1.55 !important;}\n@media(max-width:640px){\n .cd-page .deliverable-grid b{font-size:12px !important;}\n .cd-page .deliverable-grid span{font-size:15px !important;line-height:1.55 !important;}\n}\n<\/style>\n\n<style id=\"FINAL-ELEMENTOR-HEADING-ALIGNMENT\">\n\/* Lift section headings slightly inside Elementor so they align with the section numbers. *\/\n@media(min-width:901px){\n .cd-page main.content .section-card .section-heading h2{\n transform:translateY(-2px) !important;\n }\n}\n\n\n<\/style>\n<\/body><\/html>\n<style id=\"MOBILE-BROCHURE-FIX\">\n@media(max-width:640px){\n .cd-page .brochure{\n white-space:nowrap !important;\n width:100% !important;\n box-sizing:border-box !important;\n padding:13px 14px !important;\n font-size:11px !important;\n letter-spacing:.10em !important;\n line-height:1.2 !important;\n }\n}\n<\/style>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Counterparty Due Diligence | SwissMed Investments COUNTERPARTYDUE DILIGENCE EXACT SCOPE OF REVIEW Evidence-Based ReviewCorporate StandingCommercial RepresentationRisk Indicators COUNTERPARTY DUE DILIGENCE PDF \u2192 EXACT SCOPE OF REVIEW Our Counterparty Due Diligence is a structured, evidence-based review of the identity, corporate standing, commercial representation and relevant risk indicators associated with a prospective supplier, seller, trading entity or […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"full-width-container","site-content-style":"unboxed","site-sidebar-style":"unboxed","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"enabled","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-3423","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=\/wp\/v2\/pages\/3423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3423"}],"version-history":[{"count":37,"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=\/wp\/v2\/pages\/3423\/revisions"}],"predecessor-version":[{"id":3546,"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=\/wp\/v2\/pages\/3423\/revisions\/3546"}],"wp:attachment":[{"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

\n\t\t\t\t

\n\t\t\t\t\t\n\nCounterparty Due Diligence | SwissMed Investments<\/title>\n<style>\n.cd-page{--ink:#1d2b3a;--deep:#15263a;--paper:#f8f8f5;--soft:#eef1ef;--line:#d6ddd9;--accent:#4f7777;--accent2:#b59a6b;--blue:#6d8790;--muted:#69747b;--white:#fff}\n.cd-page *{box-sizing:border-box}.cd-page{scroll-behavior:smooth}.cd-page{margin:0;background:var(--paper);color:var(--ink);font-family:Arial,Helvetica,sans-serif;line-height:1.65}.cd-page a{text-decoration:none;color:inherit}\n.cd-page{overflow:hidden}.cd-page .wrap{width:min(1180px,calc(100% - 56px));margin:auto}\n.cd-page .hero{background:linear-gradient(125deg,#15263a 0%,#1d3547 55%,#365f63 100%);color:#fff;padding:105px 0 74px;position:relative}\n.cd-page .hero:after{content:\"\";position:absolute;inset:0;background:radial-gradient(circle at 82% 18%,rgba(181,154,107,.18),transparent 34%);pointer-events:none}\n.cd-page .hero-inner{position:relative;z-index:1}.cd-page .hero-kicker{font-size:12px;letter-spacing:.24em;text-transform:uppercase;color:#c8d5d4;margin-bottom:24px}\n.cd-page h1{font-size:clamp(2.45rem,5.2vw,5.35rem);line-height:.94;letter-spacing:-.055em;margin:0;max-width:930px;word-break:keep-all;overflow-wrap:normal}\n.cd-page h1{color:#fff !important}.cd-page h1 span{color:#b59a6b !important}.cd-page .elementor .hero h1, .cd-page .elementor-widget-html .hero h1{font-size:clamp(2.45rem,5.2vw,5.35rem) !important;line-height:.94 !important;letter-spacing:-.055em !important}.cd-page .elementor .hero h1 span, .cd-page .elementor-widget-html .hero h1 span{font-size:inherit !important;color:#b59a6b !important}.cd-page .hero-sub{font-size:16px;letter-spacing:.19em;text-transform:uppercase;color:#dbe3e2;margin-top:28px}\n.cd-page .hero-meta{display:flex;flex-wrap:wrap;gap:12px 28px;margin-top:34px;font-size:12px;letter-spacing:.13em;text-transform:uppercase;color:#c7d1d0}\n.cd-page .brochure{display:inline-flex;align-items:center;justify-content:center;margin-top:30px;padding:15px 25px;background:#4f7777;border:1px solid #b59a6b;color:#fff;border-radius:2px;font-size:12px;letter-spacing:.15em;text-transform:uppercase;box-shadow:0 10px 28px rgba(0,0,0,.18);transition:.25s ease}\n.cd-page .brochure:hover{background:#628b8b;transform:translateY(-2px);box-shadow:0 14px 34px rgba(0,0,0,.24)}\n.cd-page .intro-block{padding:74px 0 22px}.cd-page .section-label{font-size:11px;letter-spacing:.24em;text-transform:uppercase;color:var(--accent);font-weight:700;margin-bottom:18px}\n.cd-page .lead{font-size:clamp(20px,2.3vw,29px);line-height:1.45;max-width:920px;color:#2c3c47;margin:0}\n .cd-page .question-grid{display:grid;grid-template-columns:repeat(5,1fr);gap:14px;margin-top:34px;background:transparent;border:0}\n.cd-page .question-grid div{position:relative;background:#fff;padding:27px 21px 24px;min-height:148px;border:1px solid #d8dfdc;border-top:3px solid #6d8790;box-shadow:0 7px 20px rgba(29,43,58,.055);transition:transform .2s ease,box-shadow .2s ease}\n.cd-page .question-grid div:nth-child(2){border-top-color:#b59a6b;background:#fbfaf7}.cd-page .question-grid div:nth-child(3){border-top-color:#4f7777;background:#f7faf9}.cd-page .question-grid div:nth-child(4){border-top-color:#8a9aa1;background:#f8fafb}.cd-page .question-grid div:nth-child(5){border-top-color:#b59a6b;background:#fbfaf7}\n.cd-page .question-grid div:before{content:\"\";position:absolute;left:21px;top:18px;width:24px;height:1px;background:#b59a6b}\n.cd-page .question-grid b{display:block;color:#1d3547;font-size:10px;letter-spacing:.16em;margin:10px 0 15px;font-weight:600}.cd-page .question-grid span{font-size:15px;line-height:1.45;color:#34434c}\n@media(min-width:901px){.cd-page .question-grid div:hover{transform:translateY(-3px);box-shadow:0 11px 25px rgba(29,43,58,.09)}}\n.cd-page .content{padding:30px 0 90px}.cd-page .section-card{display:grid;grid-template-columns:92px 1fr;gap:30px;border-top:1px solid var(--line);padding:62px 0}\n.cd-page .section-no{font-size:13px;letter-spacing:.18em;color:var(--accent2);padding-top:8px;font-weight:700}.cd-page h2{font-size:clamp(25px,3vw,39px);line-height:1.12;letter-spacing:-.025em;font-weight:500;margin:0 0 16px;color:var(--deep)}\n.cd-page .section-content .intro{max-width:920px;margin:0 0 24px;font-size:17px;color:#4e5b61}.cd-page .eyebrow{font-size:10px;letter-spacing:.2em;text-transform:uppercase;color:var(--accent);font-weight:700;margin:28px 0 13px}\n.cd-page .checklist{display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:0 28px;padding:0;margin:0;list-style:none;max-width:1000px}\n.cd-page .checklist li{position:relative;padding:10px 0 10px 22px;border-bottom:1px solid #e5e8e5;font-size:15px;color:#33434b}\n.cd-page .checklist li:before{content:\"\";position:absolute;left:0;top:18px;width:6px;height:6px;border-radius:50%;background:var(--accent2)}\n.cd-page .highlight{font-size:20px;line-height:1.5;color:var(--deep);margin:12px 0;max-width:1000px}\n.cd-page .note{font-size:14px;color:#657177;max-width:980px;margin:25px 0 0}\n.cd-page .deliverable-grid{display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:1px;background:var(--line);border:1px solid var(--line);margin-top:28px}\n.cd-page .deliverable-grid div{background:#fff;padding:23px 24px;min-height:110px}.cd-page .deliverable-grid b{display:block;color:var(--accent);font-size:12px;letter-spacing:.08em;margin-bottom:8px}.cd-page .deliverable-grid span{font-size:14px;color:#56636a}\n.cd-page .matrix-title{margin:42px 0 14px;font-size:11px;letter-spacing:.22em;text-transform:uppercase;color:var(--accent);font-weight:700}\n.cd-page .matrix{width:100%;border-collapse:collapse;background:#fff;border:1px solid var(--line);font-size:14px}.cd-page .matrix th, .cd-page .matrix td{padding:15px 17px;border-bottom:1px solid var(--line);text-align:left;vertical-align:top}.cd-page .matrix th{background:var(--soft);color:var(--deep);font-size:10px;letter-spacing:.16em;text-transform:uppercase}.cd-page .matrix td:first-child{width:36%;font-weight:600;color:#33444c}\n.cd-page .principle{margin-top:25px;background:linear-gradient(135deg,#15263a,#23464f);color:#fff;padding:70px 8%;position:relative;overflow:hidden}.cd-page .principle:after{content:\"\";position:absolute;width:320px;height:320px;border:1px solid rgba(181,154,107,.3);border-radius:50%;right:-110px;top:-110px}\n.cd-page .principle .section-label{color:#b59a6b}.cd-page .principle h2{color:#fff;max-width:850px;font-size:clamp(28px,4vw,48px)}\n.cd-page .principle h2{font-family:Arial,Helvetica,sans-serif !important;}.cd-page .principle .principle-lines{font-size:18px;letter-spacing:.11em;text-transform:uppercase;color:#dce6e4;line-height:2;position:relative;z-index:1}.cd-page .principle p{max-width:880px;color:#d0dbda;position:relative;z-index:1}\n@media(max-width:900px){.cd-page .wrap{width:min(100% - 38px,720px)}.cd-page .question-grid{grid-template-columns:repeat(2,1fr)}.cd-page .question-grid div:last-child{grid-column:1\/-1}.cd-page .section-card{grid-template-columns:62px 1fr;gap:18px}.cd-page .deliverable-grid{grid-template-columns:1fr}}\n@media(max-width:640px){.cd-page .wrap{width:calc(100% - 30px)}.cd-page .hero{padding:70px 0 54px}.cd-page h1{font-size:39px !important;line-height:1.06;letter-spacing:-.035em}.cd-page .hero-sub{font-size:12px;line-height:1.6;letter-spacing:.12em}.cd-page .hero-meta{gap:9px 18px;font-size:10px}.cd-page .brochure{width:100%;margin-top:26px}.cd-page .intro-block{padding:52px 0 12px}.cd-page .lead{font-size:20px}.cd-page .question-grid{grid-template-columns:1fr}.cd-page .question-grid div:last-child{grid-column:auto}.cd-page .section-card{grid-template-columns:1fr;gap:8px;padding:45px 0}.cd-page .section-no{padding:0}.cd-page h2{font-size:29px}.cd-page .section-content .intro{font-size:16px}.cd-page .checklist{grid-template-columns:1fr}.cd-page .checklist li{font-size:14px}.cd-page .highlight{font-size:17px}.cd-page .matrix{font-size:12px}.cd-page .matrix th, .cd-page .matrix td{padding:11px 10px}.cd-page .matrix td:first-child{width:40%}.cd-page .principle{padding:52px 28px}.cd-page .principle .principle-lines{font-size:14px;letter-spacing:.07em}}\n\n\/* v33 targeted refinements *\/\n.cd-page .section-card .section-heading h2{color:#B59A6B !important;}\n.cd-page .section-content .objective-lead{margin-top:25px !important;margin-bottom:8px !important;}\n.cd-page .section-content .objective-line{margin:0 !important;line-height:1.45 !important;}\n.cd-page .section-content .objective-and{margin:2px 0 !important;line-height:1.35 !important;}\n<\/style>\n\n\n\n\n\n\n\n\n\n\n\n\n<style id=\"VISIBLE-TWO-BACKGROUNDS\">\n.cd-page main.content .section-card{\n position:relative;\n isolation:isolate;\n z-index:0;\n}\n.cd-page main.content .section-card::before{\n content:\"\";\n position:absolute;\n z-index:-1;\n top:0;\n bottom:0;\n left:50%;\n width:100vw;\n transform:translateX(-50%);\n background:#F4F5F3 !important;\n}\n.cd-page main.content .section-card:nth-of-type(even)::before{\n background:#E8F0F3 !important;\n}\n\/* Keep the closing THE PRINCIPLE section untouched. *\/\n<\/style>\n\n\n<style id=\"MINIMAL-CARD-REFINEMENT\">\n\/* Minimal card refinement *\/\n.cd-page .section-card .checklist{\n gap:0 30px;\n}\n.cd-page .section-card .checklist li{\n padding:9px 0 9px 20px;\n border-bottom:1px solid rgba(79,119,119,.14);\n}\n.cd-page .section-card .checklist li:before{\n width:5px;\n height:5px;\n top:17px;\n background:#B59A6B;\n}\n.cd-page .section-card .eyebrow{\n color:#4F7777;\n position:relative;\n padding-bottom:8px;\n}\n.cd-page .section-card .eyebrow:after{\n content:\"\";\n display:block;\n width:34px;\n height:1px;\n margin-top:7px;\n background:#B59A6B;\n}\n.cd-page .section-card .note:first-of-type{\n color:#4F7777;\n letter-spacing:.12em;\n text-transform:uppercase;\n font-size:10px;\n font-weight:700;\n}\n\n\/* Make the existing deliverable matrix\/cards feel more like restrained information panels *\/\n.cd-page .deliverable-grid{\n background:rgba(214,221,217,.65);\n border-color:rgba(214,221,217,.65);\n gap:1px;\n}\n.cd-page .deliverable-grid div{\n background:rgba(255,255,255,.72);\n padding:20px 22px;\n}\n.cd-page .deliverable-grid b{\n color:#1D2B3A;\n}\n.cd-page .matrix{\n background:rgba(255,255,255,.78);\n}\n.cd-page .matrix th{\n background:rgba(232,240,243,.72);\n}\n\n\/* Subtle emphasis for important inline findings *\/\n.cd-page .highlight{\n border-left:2px solid #B59A6B;\n padding-left:16px;\n}\n\n\/* Keep the design spacious rather than over-decorated *\/\n.cd-page .section-card{\n padding:58px 0;\n}\n<\/style>\n\n\n<style id=\"COLORFUL-CARDS-ONLY\">\n\/* Only the internal cards get color; the v13 layout remains unchanged. *\/\n.cd-page .deliverable-grid div:nth-child(3n\/**\/+1){\n background:#E8F0F3 !important;\n}\n.cd-page .deliverable-grid div:nth-child(3n\/**\/+2){\n background:#F3EEE5 !important;\n}\n.cd-page .deliverable-grid div:nth-child(3n){\n background:#EAF1EF !important;\n}\n\n.cd-page .matrix th{\n background:#E8F0F3 !important;\n}\n.cd-page .matrix tbody tr:nth-child(odd) td{\n background:#F8F8F5 !important;\n}\n.cd-page .matrix tbody tr:nth-child(even) td{\n background:#EEF2F5 !important;\n}\n<\/style>\n\n\n<style id=\"DUE-DILIGENCE-MATRIX-REFINEMENT\">\n\/* Refine only the K. Verification Matrix inside DUE DILIGENCE DELIVERABLE *\/\n.cd-page .matrix-title{\n margin-top:44px !important;\n margin-bottom:16px !important;\n color:#4F7777 !important;\n position:relative;\n}\n.cd-page .matrix-title:after{\n content:\"\";\n display:block;\n width:42px;\n height:2px;\n margin-top:9px;\n background:#B59A6B;\n}\n.cd-page .matrix{\n border:1px solid #D6DDD9 !important;\n border-collapse:separate !important;\n border-spacing:0 !important;\n border-radius:4px !important;\n overflow:hidden !important;\n box-shadow:0 8px 22px rgba(29,43,58,.06);\n}\n.cd-page .matrix th{\n padding:16px 18px !important;\n background:#1D3547 !important;\n color:#fff !important;\n border-bottom:0 !important;\n font-size:10px !important;\n letter-spacing:.18em !important;\n}\n.cd-page .matrix th:first-child{\n width:36% !important;\n}\n.cd-page .matrix td{\n padding:15px 18px !important;\n border-bottom:1px solid #DDE3E0 !important;\n color:#40505A !important;\n background:#F8F8F5 !important;\n}\n.cd-page .matrix tbody tr:nth-child(even) td{\n background:#E8F0F3 !important;\n}\n.cd-page .matrix tbody tr:last-child td{\n border-bottom:0 !important;\n}\n.cd-page .matrix td:first-child{\n color:#1D2B3A !important;\n font-weight:600 !important;\n letter-spacing:.01em;\n}\n.cd-page .matrix td:nth-child(2){\n color:#596970 !important;\n}\n<\/style>\n\n\n<style id=\"DELIVERABLE-GRID-PREMIUM\">\n\/* Refine only the A\u2013J deliverable cards above the Verification Matrix *\/\n.cd-page .deliverable-grid{\n gap:0 !important;\n background:#D9E1DE !important;\n border:1px solid #D2DCD8 !important;\n border-radius:5px !important;\n overflow:hidden !important;\n box-shadow:0 8px 24px rgba(29,43,58,.055) !important;\n}\n.cd-page .deliverable-grid div{\n position:relative;\n background:#FAFAF7 !important;\n padding:24px 25px 23px 27px !important;\n min-height:118px !important;\n border:0 !important;\n}\n.cd-page .deliverable-grid div:nth-child(4n\/**\/+1), .cd-page .deliverable-grid div:nth-child(4n\/**\/+4){\n background:#F4F5F3 !important;\n}\n.cd-page .deliverable-grid div:nth-child(4n\/**\/+2){\n background:#EAF1F1 !important;\n}\n.cd-page .deliverable-grid div:nth-child(4n\/**\/+3){\n background:#F3EEE5 !important;\n}\n.cd-page .deliverable-grid div:before{\n content:\"\";\n position:absolute;\n left:0;\n top:0;\n bottom:0;\n width:3px;\n background:#4F7777;\n}\n.cd-page .deliverable-grid div:nth-child(3n):before{\n background:#B59A6B;\n}\n.cd-page .deliverable-grid b{\n margin-bottom:9px !important;\n color:#1D3547 !important;\n font-size:10px !important;\n letter-spacing:.13em !important;\n line-height:1.45 !important;\n}\n.cd-page .deliverable-grid span{\n display:block;\n font-size:13px !important;\n line-height:1.65 !important;\n color:#596970 !important;\n max-width:48ch;\n}\n@media(max-width:900px){\n .cd-page .deliverable-grid div{padding:22px 23px 21px 25px !important;}\n}\n@media(max-width:640px){\n .cd-page .deliverable-grid div{padding:21px 20px 20px 23px !important;min-height:0 !important;}\n .cd-page .deliverable-grid b{font-size:10px !important;}\n .cd-page .deliverable-grid span{font-size:13px !important;}\n}\n<\/style>\n\n<style id=\"THE-PRINCIPLE-COLOR-REFINEMENT\">\n.cd-page .principle{\n background:linear-gradient(135deg,#142B3B 0%,#1E4650 58%,#315F61 100%) !important;\n}\n.cd-page .principle:after{\n width:360px !important;height:360px !important;\n border:1px solid rgba(181,154,107,.34) !important;\n box-shadow:0 0 0 70px rgba(181,154,107,.035);\n}\n.cd-page .principle .section-label{\n color:#C9A96E !important;\n letter-spacing:.27em;\n}\n.cd-page .principle h2{\n color:#F7F8F5 !important;\n}\n.cd-page .principle h2 br{\n \/* retain exact line breaks *\/\n}\n.cd-page .principle .principle-lines{\n color:#E2ECEA !important;\n border-left:2px solid #B59A6B;\n padding-left:20px;\n margin:25px 0;\n}\n.cd-page .principle p{\n color:#D0DEDC !important;\n}\n<\/style>\n\n<style id=\"BROCHURE-HOVER-FIX\">\n.cd-page .brochure:hover{\n background:#4f7777 !important;\n color:#ffffff !important;\n border-color:#b59a6b !important;\n transform:none !important;\n box-shadow:0 10px 28px rgba(0,0,0,.18) !important;\n}\n.cd-page .brochure:focus, .cd-page .brochure:active{\n color:#ffffff !important;\n}\n<\/style>\n<style id=\"SECTION-HEADINGS-LEFT\">.cd-page .section-card{grid-template-columns:300px 1fr !important;gap:28px !important;align-items:start}.cd-page .section-heading{display:flex;align-items:flex-start;gap:18px;padding-top:7px;transform:translateY(-4px)}.cd-page .section-heading .section-no{flex:0 0 auto;padding-top:0;font-size:13px;letter-spacing:.18em;color:#B59A6B;font-weight:700}.cd-page .section-heading h2{transform:none;margin:0!important;color:#B59A6B!important;font-size:13px!important;line-height:1.45!important;letter-spacing:.16em!important;font-weight:700!important;text-transform:uppercase!important}@media(max-width:900px){.cd-page .section-card{grid-template-columns:1fr!important;gap:10px!important}.cd-page .section-heading{padding-top:0;gap:15px;transform:none}.cd-page .section-heading h2{font-size:13px!important}}@media(max-width:640px){.cd-page .section-heading{gap:12px}.cd-page .section-heading .section-no{font-size:12px}.cd-page .section-heading h2{font-size:12px!important;line-height:1.5!important}}<\/style>\n<style>\n\/* v31 \u2014 Section 05: tighter evidence lines *\/\n.cd-page .section-card:nth-of-type(5) .section-content strong{\n font-weight: 700;\n}\n.cd-page .section-card:nth-of-type(5) .section-content p{\n margin-bottom: 10px !important;\n}\n.cd-page .section-card:nth-of-type(5) .section-content p + p{\n margin-top: 4px !important;\n}\n<\/style>\n\n<style>\n\/* v32 \u2014 Section 05: tighter spacing around \u201cand\u201d *\/\n.cd-page .section-card:nth-of-type(5) .section-content p:nth-of-type(3){\n margin-bottom: 2px !important;\n}\n.cd-page .section-card:nth-of-type(5) .section-content p:nth-of-type(4){\n margin-top: 0 !important;\n margin-bottom: 0 !important;\n line-height: 1.2 !important;\n}\n.cd-page .section-card:nth-of-type(5) .section-content p:nth-of-type(5){\n margin-top: 2px !important;\n}\n<\/style>\n\n<style id=\"v34-fixes\">\n\/* v34 \u2014 equal spacing around \u201cand\u201d + section 14\/15 heading alignment *\/\n.cd-page .section-card:nth-of-type(5) .section-content .objective-line{\n margin: 2px 0 !important;\n line-height: 1.45 !important;\n}\n.cd-page .section-card:nth-of-type(5) .section-content .objective-and{\n margin: 2px 0 !important;\n line-height: 1.2 !important;\n}\n.cd-page .section-card:nth-of-type(5) .section-content .objective-lead{\n margin-bottom: 4px !important;\n}\n<\/style>\n<\/head>\n<body>\n<div class=\"cd-page\">\n<header class=\"hero\"><div class=\"wrap hero-inner\">\n<div class=\"hero-kicker\"><\/div>\n<h1>COUNTERPARTY<br><span>DUE DILIGENCE<\/span><\/h1>\n<div class=\"hero-sub\">EXACT SCOPE OF REVIEW<\/div>\n<div class=\"hero-meta\"><span>Evidence-Based Review<\/span><span>Corporate Standing<\/span><span>Commercial Representation<\/span><span>Risk Indicators<\/span><\/div>\n<a class=\"brochure\" href=\"https:\/\/swissmedinvestments.com\/wp-content\/uploads\/2026\/09\/brochure-COUNTERPARTY-DUE-DILIGENCE.pdf\" target=\"_blank\" rel=\"noopener\">COUNTERPARTY DUE DILIGENCE PDF \u2192<\/a>\n<\/div><\/header>\n<section class=\"intro-block\"><div class=\"wrap\">\n<div class=\"section-label\">EXACT SCOPE OF REVIEW<\/div>\n<p class=\"lead\">Our Counterparty Due Diligence is a structured, evidence-based review of the identity, corporate standing, commercial representation and relevant risk indicators associated with a prospective supplier, seller, trading entity or authorized representative.<\/p>\n<p style=\"margin:24px 0 0;color:#59666c;font-size:16px\">The scope is designed to answer five fundamental questions:<\/p>\n<div class=\"question-grid\">\n<div><b>01<\/b><span>WHO IS THE COUNTERPARTY?<\/span><\/div>\n<div><b>02<\/b><span>WHO OWNS AND CONTROLS THE ENTITY?<\/span><\/div>\n<div><b>03<\/b><span>WHAT IS THE COUNTERPARTY REPRESENTING?<\/span><\/div>\n<div><b>04<\/b><span>WHAT CAN BE INDEPENDENTLY VERIFIED?<\/span><\/div>\n<div><b>05<\/b><span>WHAT MATERIAL RED FLAGS OR INFORMATION GAPS EXIST?<\/span><\/div>\n<\/div>\n<\/div><\/section>\n<main class=\"content\"><div class=\"wrap\">\n<section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">01<\/div><h2>CORPORATE IDENTITY & EXISTENCE<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Verification and review of the legal identity of the proposed counterparty.<\/p><div class=\"eyebrow\">Scope includes:<\/div><ul class=\"checklist\"><li>Full legal entity name<\/li><li>Trading name \/ commercial name<\/li><li>Registration number<\/li><li>Date of incorporation<\/li><li>Registered jurisdiction<\/li><li>Registered office<\/li><li>Current corporate status<\/li><li>Nature of business<\/li><li>Available corporate filings<\/li><li>Official corporate registry information<\/li><li>Identification of relevant subsidiaries or affiliated entities, where identifiable<\/li><\/ul><p class=\"note\">Objective<\/p><p class=\"note\">To establish that the entity exists, is identifiable and corresponds to the entity presented in the commercial proposition.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">02<\/div><h2>OWNERSHIP & CONTROL<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Assessment of the available information concerning ownership and control.<\/p><div class=\"eyebrow\">Scope includes:<\/div><ul class=\"checklist\"><li>Shareholding structure<\/li><li>Ultimate Beneficial Owner (UBO), where publicly identifiable or appropriately documented<\/li><li>Directors<\/li><li>Officers<\/li><li>Authorized representatives<\/li><li>Parent companies<\/li><li>Affiliates<\/li><li>Related entities<\/li><li>Changes in ownership or management, where relevant and available<\/li><\/ul><p class=\"note\">Objective<\/p><p class=\"note\">To establish who ultimately owns, controls or represents the entity, and whether the individuals presented to the buyer appear to have the authority they claim.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">03<\/div><h2>REPRESENTATION & MANDATE VERIFICATION<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Where a party claims to act on behalf of a producer, refinery, trading company, supplier or other principal, the representation itself becomes a critical part of the review.<\/p><div class=\"eyebrow\">Scope includes:<\/div><ul class=\"checklist\"><li>Identity of the claimed principal<\/li><li>Identity of the representative<\/li><li>Claimed relationship with the principal<\/li><li>Nature and scope of the mandate<\/li><li>Validity period, where available<\/li><li>Consistency between the representative's claims and available corporate information<\/li><li>Supporting authorization or mandate documentation, where provided<\/li><li>Verification of the relationship through independent channels where reasonably possible<\/li><\/ul><p class=\"note\">Objective<\/p><p class=\"note\">To distinguish between:<\/p><p class=\"note\">Direct Principal \u2192 Authorized Representative \u2192 Independent Intermediary \u2192 Unverified Claim of Representation<\/p><p class=\"note\">No mandate is treated as verified solely because a document has been presented.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">04<\/div><h2>MANAGEMENT & KEY PERSONNEL<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Review of individuals materially involved in the proposed transaction.<\/p><div class=\"eyebrow\">Scope includes:<\/div><ul class=\"checklist\"><li>Directors<\/li><li>Senior management<\/li><li>Authorized signatories<\/li><li>Commercial representatives<\/li><li>Beneficial owners, where identifiable<\/li><li>Relevant professional \/ corporate affiliations<\/li><li>Publicly available professional information<\/li><\/ul><p class=\"note\">Review focus:<\/p><ul class=\"checklist\"><li>Identity consistency<\/li><li>Corporate association<\/li><li>Role and authority<\/li><li>Relevant public information<\/li><li>Potential adverse indicators<\/li><\/ul><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">05<\/div><h2>COMMERCIAL PROFILE<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Assessment of whether the counterparty's stated business profile is broadly consistent with the proposed transaction.<\/p><div class=\"eyebrow\">Scope includes:<\/div><ul class=\"checklist\"><li>Stated business activities<\/li><li>Trading profile<\/li><li>Product categories<\/li><li>Geographic footprint<\/li><li>Claimed market position<\/li><li>Historical activity, where independently available<\/li><li>Relevant counterparties or commercial relationships, where publicly verifiable<\/li><li>Stated supply capability<\/li><li>Proposed transaction structure<\/li><\/ul><p class=\"note\">Objective<\/p><p class=\"note objective-lead\">To identify material discrepancies between:<\/p><p class=\"note objective-line\"><strong>What the entity claims to do<\/strong><\/p><p class=\"note objective-and\">and<\/p><p class=\"note objective-line\"><strong>What available evidence indicates it actually does.<\/strong><\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">06<\/div><h2>PRODUCT & SUPPLY CLAIMS<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Review of the information supporting the proposed supply opportunity.<\/p><div class=\"eyebrow\">Scope may include:<\/div><ul class=\"checklist\"><li>Product name<\/li><li>Product specification<\/li><li>Origin<\/li><li>Indicative quantity<\/li><li>Availability period<\/li><li>Loading point<\/li><li>Terminal \/ refinery information, where applicable<\/li><li>Delivery structure<\/li><li>Proposed Incoterms<\/li><li>Pricing structure<\/li><li>Allocation \/ availability claims<\/li><li>Supporting commercial documentation<\/li><\/ul><p class=\"note\">Objective<\/p><p class=\"note\">To determine whether the commercial proposition is internally consistent and sufficiently documented to justify further investigation.<\/p><p class=\"note\">This review does not constitute physical inspection, title verification, inventory certification or confirmation of actual product availability unless separately mandated and independently performed by the appropriate parties.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">07<\/div><h2>DOCUMENT AUTHENTICITY & CONSISTENCY REVIEW<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Review of documents supplied during the engagement.<\/p><div class=\"eyebrow\">Documents may include:<\/div><ul class=\"checklist\"><li>Certificates of incorporation<\/li><li>Corporate extracts<\/li><li>Licenses<\/li><li>Certificates<\/li><li>Company profiles<\/li><li>Mandates<\/li><li>Letters of authorization<\/li><li>Commercial offers<\/li><li>Product specifications<\/li><li>Invoices<\/li><li>Contracts \/ draft contracts<\/li><li>Logistics documentation<\/li><li>Other transaction-related materials<\/li><\/ul><p class=\"note\">Review focuses on:<\/p><ul class=\"checklist\"><li>Internal consistency<\/li><li>Entity names<\/li><li>Dates<\/li><li>Registration information<\/li><li>Signatories<\/li><li>Corporate details<\/li><li>Contact information<\/li><li>Formatting and structural inconsistencies<\/li><li>Cross-reference against independently available information<\/li><\/ul><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">08<\/div><h2>SANCTIONS & RESTRICTED-PARTY SCREENING<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Screening of the relevant entities and individuals against applicable publicly available sanctions and restricted-party information.<\/p><div class=\"eyebrow\">Screening may cover:<\/div><ul class=\"checklist\"><li>Legal entity<\/li><li>Parent \/ affiliated entities<\/li><li>Directors<\/li><li>Beneficial owners, where identifiable<\/li><li>Key representatives<\/li><li>Relevant transaction parties<\/li><\/ul><p class=\"note\">Potential areas include:<\/p><ul class=\"checklist\"><li>Sanctions lists<\/li><li>Restricted-party lists<\/li><li>Government enforcement information<\/li><li>Regulatory actions<\/li><li>Export-control related restrictions<\/li><\/ul><p class=\"note\">The applicable screening scope depends on the jurisdictions, entities, individuals and transaction structure involved.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">09<\/div><h2>ADVERSE MEDIA & REPUTATIONAL SCREENING<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Review of credible publicly available information for material adverse indicators.<\/p><div class=\"eyebrow\">Search areas may include:<\/div><ul class=\"checklist\"><li>Fraud allegations<\/li><li>Financial crime allegations<\/li><li>Corruption-related matters<\/li><li>Sanctions \/ regulatory issues<\/li><li>Litigation of material relevance<\/li><li>Enforcement actions<\/li><li>Misrepresentation allegations<\/li><li>Corporate misconduct<\/li><li>Significant commercial disputes<\/li><\/ul><p class=\"note\">Findings are distinguished between:<\/p><p class=\"note\">Verified Facts | Official Proceedings | Reported Allegations | Unsubstantiated Claims<\/p><p class=\"note\">No adverse-media finding is treated as established fact solely because it has been reported publicly.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">10<\/div><h2>LITIGATION & REGULATORY REVIEW<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Where reliable public information is available, review may include:<\/p><ul class=\"checklist\"><li>Material litigation<\/li><li>Regulatory proceedings<\/li><li>Government enforcement actions<\/li><li>Insolvency \/ bankruptcy indicators<\/li><li>Corporate disputes<\/li><li>Relevant judgments or official decisions<\/li><\/ul><p class=\"note\">The availability and completeness of such information varies significantly by jurisdiction.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">11<\/div><h2>DIGITAL & CONTACT VERIFICATION<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">Assessment of the consistency of publicly presented contact and digital information.<\/p><div class=\"eyebrow\">May include:<\/div><ul class=\"checklist\"><li>Corporate website<\/li><li>Corporate domain<\/li><li>Official email domain<\/li><li>Published telephone information<\/li><li>Physical address<\/li><li>Public corporate profiles<\/li><li>Digital presence<\/li><li>Consistency between online and corporate information<\/li><\/ul><p class=\"note\">Particular attention is given to discrepancies between:<\/p><p class=\"note\">Corporate Identity \u2192 Domain \u2192 Email \u2192 Address \u2192 Personnel \u2192 Commercial Documentation<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">12<\/div><h2>RED-FLAG ANALYSIS<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">All material findings are evaluated for potential indicators requiring further investigation.<\/p><div class=\"eyebrow\">Examples include:<\/div><ul class=\"checklist\"><li>Inconsistent corporate information<\/li><li>Unclear ownership<\/li><li>Unverifiable representation<\/li><li>Conflicting company addresses<\/li><li>Inconsistent domains or email addresses<\/li><li>Unsupported supply claims<\/li><li>Unusual documentation<\/li><li>Material gaps in corporate information<\/li><li>Sanctions-related indicators<\/li><li>Significant adverse regulatory information<\/li><li>Unexplained changes in corporate identity<\/li><li>Pressure to bypass normal verification procedures<\/li><\/ul><p class=\"note\">A red flag is an indicator requiring investigation, not automatically proof of misconduct.<\/p><\/div><\/section><section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">13<\/div><h2>INFORMATION GAP ANALYSIS<\/h2><\/div><div class=\"section-content\"><p class=\"intro\">A professional due diligence process should identify not only what is known, but also what cannot be established.<\/p><div class=\"eyebrow\">The review therefore identifies:<\/div><ul class=\"checklist\"><li>VERIFIED \u2014 Information supported by reliable evidence.<\/li><li>CORROBORATED \u2014 Information supported by more than one relevant source.<\/li><li>UNVERIFIED \u2014 Information for which adequate independent evidence has not been identified.<\/li><li>INCONSISTENT \u2014 Information that conflicts with available evidence.<\/li><li>OUTSTANDING \u2014 Information or documentation required for further assessment.<\/li><\/ul><p class=\"note\">This distinction is fundamental to the final assessment.<\/p><\/div><\/section>\n\n<section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">14<\/div><h2>DUE DILIGENCE DELIVERABLE<\/h2><\/div><div class=\"section-content\">\n<p class=\"intro\">Subject to the agreed engagement scope, the client receives a structured Counterparty Due Diligence Report containing:<\/p>\n<div class=\"deliverable-grid\">\n<div><b>A. Executive Summary<\/b><span>Concise overview of the counterparty and principal findings.<\/span><\/div>\n<div><b>B. Corporate Profile<\/b><span>Legal identity, jurisdiction, registration and corporate structure.<\/span><\/div>\n<div><b>C. Ownership & Management<\/b><span>Available ownership, UBO and management information.<\/span><\/div>\n<div><b>D. Representation<\/b><span>Assessment of the claimed mandate or commercial representation.<\/span><\/div>\n<div><b>E. Commercial Profile<\/b><span>Business activity and transaction-related information.<\/span><\/div>\n<div><b>F. Documentation Review<\/b><span>Summary of documents reviewed and material inconsistencies identified.<\/span><\/div>\n<div><b>G. Sanctions \/ Restricted-Party Screening<\/b><span>Screening results and relevant observations.<\/span><\/div>\n<div><b>H. Adverse Media<\/b><span>Material publicly available findings and source attribution.<\/span><\/div>\n<div><b>I. Litigation \/ Regulatory<\/b><span>Relevant publicly available proceedings or enforcement information.<\/span><\/div>\n<div><b>J. Red-Flag & Information-Gap Analysis<\/b><span>Outstanding issues requiring clarification or additional evidence.<\/span><\/div>\n<\/div>\n<div class=\"matrix-title\">K. Verification Matrix<\/div>\n<table class=\"matrix\"><thead><tr><th>Category<\/th><th>Status<\/th><\/tr><\/thead><tbody>\n<tr><td>Corporate Identity<\/td><td>Verified \/ Partially Verified \/ Unverified<\/td><\/tr>\n<tr><td>Ownership<\/td><td>Verified \/ Partially Verified \/ Unverified<\/td><\/tr>\n<tr><td>Management<\/td><td>Verified \/ Partially Verified \/ Unverified<\/td><\/tr>\n<tr><td>Representation<\/td><td>Verified \/ Partially Verified \/ Unverified<\/td><\/tr>\n<tr><td>Commercial Profile<\/td><td>Corroborated \/ Partially Corroborated \/ Unverified<\/td><\/tr>\n<tr><td>Documentation<\/td><td>Consistent \/ Inconsistent \/ Incomplete<\/td><\/tr>\n<tr><td>Sanctions Screening<\/td><td>No Relevant Match Identified \/ Potential Match \/ Requires Review<\/td><\/tr>\n<tr><td>Adverse Media<\/td><td>No Material Finding Identified \/ Finding \/ Requires Review<\/td><\/tr>\n<tr><td>Litigation \/ Regulatory<\/td><td>No Material Finding Identified \/ Finding \/ Requires Review<\/td><\/tr>\n<tr><td>Key Red Flags<\/td><td>Identified \/ None Identified \/ Further Review Required<\/td><\/tr>\n<tr><td>Outstanding Information<\/td><td>Listed in Report<\/td><\/tr>\n<\/tbody><\/table>\n<\/div><\/section>\n\n<section class=\"section-card\"><div class=\"section-heading\"><div class=\"section-no\">15<\/div><h2>SCOPE LIMITATIONS<\/h2><\/div><div class=\"section-content\">\n<p class=\"intro\">The due diligence service is a commercial and counterparty risk-screening exercise.<\/p>\n<p class=\"intro\">It does not, unless separately contracted and independently performed by appropriately qualified professionals, constitute:<\/p>\n<ul class=\"checklist\">\n<li>Legal due diligence<\/li><li>Audit<\/li><li>Financial statement verification<\/li><li>Credit rating<\/li><li>Banking verification<\/li><li>Regulatory certification<\/li><li>Sanctions clearance by a competent authority<\/li><li>Physical inspection of petroleum products<\/li><li>Verification of physical inventory<\/li><li>Title certification<\/li><li>Refinery confirmation<\/li><li>Terminal confirmation<\/li><li>Guarantee of product availability<\/li><li>Guarantee of transaction performance<\/li><li>Guarantee of counterparty solvency<\/li>\n<\/ul>\n<p class=\"note\">Where a matter requires specialist confirmation, the relevant legal, compliance, banking, inspection, logistics or other professional adviser should be engaged.<\/p>\n<\/div><\/section>\n<section class=\"principle\">\n<div class=\"section-label\">THE PRINCIPLE<\/div>\n<h2>VERIFY WHAT CAN BE VERIFIED.<br>IDENTIFY WHAT CANNOT.<br>FLAG WHAT REQUIRES FURTHER INVESTIGATION.<\/h2>\n<p>The purpose of the process is not to provide a superficial \u201capproved \/ rejected\u201d label.<\/p>\n<p>It is to give the client a structured understanding of:<\/p>\n<div class=\"principle-lines\">WHO THE COUNTERPARTY IS<br>WHAT THEY REPRESENT<br>WHAT CAN BE SUBSTANTIATED<br>WHAT REMAINS UNVERIFIED<br>WHAT POTENTIAL RED FLAGS EXIST<br>WHAT SHOULD BE CLARIFIED BEFORE FURTHER COMMERCIAL COMMITMENT<\/div>\n<p>This creates a more disciplined foundation for the next stage of the commercial relationship.<\/p>\n<\/section>\n<\/div><\/main>\n<\/div>\n\n<style>\n\/* v29: section headings match the section-number color; brochure button gets a lighter hover background *\/\n.cd-page .section-heading h2{color:#B59A6B!important;}\n.cd-page .brochure:hover, .cd-page .brochure:focus-visible{background:#6D9696!important;border-color:#B59A6B!important;color:#FFFFFF!important;}\n<\/style>\n\n\n\n<style id=\"ENERGY-EDITORIAL-ARCHITECTURE\">\n\/* Shared editorial section architecture \u2014 aligned with Independent Energy Supply *\/\n.cd-page main.content .section-card{\n display:grid !important;\n grid-template-columns:300px minmax(0,1fr) !important;\n gap:28px !important;\n align-items:start !important;\n border-top:1px solid var(--line) !important;\n padding:82px 0 !important;\n}\n.cd-page main.content .section-card .section-heading{\n display:flex !important;\n align-items:flex-start !important;\n gap:18px !important;\n padding:0 !important;\n margin:0 !important;\n transform:none !important;\n}\n.cd-page main.content .section-card .section-heading .section-no{\n flex:0 0 auto !important;\n padding:0 !important;\n margin:0 !important;\n font-size:13px !important;\n line-height:1.45 !important;\n letter-spacing:.18em !important;\n color:#B59A6B !important;\n font-weight:700 !important;\n}\n.cd-page main.content .section-card .section-heading h2{\n margin:0 !important;\n padding:0 !important;\n transform:none !important;\n color:#B59A6B !important;\n font-size:13px !important;\n line-height:1.45 !important;\n letter-spacing:.16em !important;\n font-weight:700 !important;\n text-transform:uppercase !important;\n}\n\/* The body starts slightly below the editorial heading, as on the Energy page. *\/\n.cd-page main.content .section-card .section-content{\n margin:0 !important;\n padding:15px 0 0 !important;\n min-width:0 !important;\n}\n.cd-page main.content .section-card .section-content .intro{\n margin-top:0 !important;\n}\n\/* Keep the Elementor hero typography controlled by the page itself. *\/\n.cd-page .elementor .hero h1, .cd-page .elementor-widget-html .hero h1{\n font-size:clamp(42px,7.2vw,96px) !important;\n}\n.cd-page .elementor .hero h1 span, .cd-page .elementor-widget-html .hero h1 span{\n font-size:inherit !important;\n}\n@media(max-width:900px){\n .cd-page main.content .section-card{\n grid-template-columns:1fr !important;\n gap:10px !important;\n padding:62px 0 !important;\n }\n .cd-page main.content .section-card .section-heading{\n gap:15px !important;\n transform:none !important;\n }\n .cd-page main.content .section-card .section-content{\n padding:8px 0 0 !important;\n }\n}\n@media(max-width:640px){\n .cd-page main.content .section-card{padding:45px 0 !important;}\n .cd-page main.content .section-card .section-heading{gap:12px !important;}\n .cd-page main.content .section-card .section-heading .section-no{font-size:12px !important;line-height:1.5 !important;}\n .cd-page main.content .section-card .section-heading h2{font-size:12px !important;line-height:1.5 !important;}\n}\n\n\/* Hero typography aligned with Independent Energy Supply Origination *\/\n.cd-page .hero h1{font-size:clamp(2.45rem,5.2vw,5.35rem) !important;line-height:.94 !important;letter-spacing:-.055em !important;max-width:930px !important;}\n.cd-page .hero h1 span{display:inline;color:#b59a6b !important;font-size:inherit !important;}\n@media(max-width:560px){.cd-page .hero h1{font-size:clamp(2rem,10vw,2.65rem) !important;line-height:.96 !important;letter-spacing:-.045em !important;word-break:keep-all !important;overflow-wrap:normal !important;hyphens:none !important;}}\n<\/style>\n\n<style id=\"DELIVERABLE-TYPOGRAPHY-ELEMENTOR\">\n\/* Final Elementor-safe typography for the A\u2013J Deliverable cards *\/\n.cd-page .deliverable-grid b{font-size:12px !important;line-height:1.35 !important;}\n.cd-page .deliverable-grid span{font-size:15px !important;line-height:1.55 !important;}\n@media(max-width:640px){\n .cd-page .deliverable-grid b{font-size:12px !important;}\n .cd-page .deliverable-grid span{font-size:15px !important;line-height:1.55 !important;}\n}\n<\/style>\n\n<style id=\"FINAL-ELEMENTOR-HEADING-ALIGNMENT\">\n\/* Lift section headings slightly inside Elementor so they align with the section numbers. *\/\n@media(min-width:901px){\n .cd-page main.content .section-card .section-heading h2{\n transform:translateY(-2px) !important;\n }\n}\n\n\n<\/style>\n<\/body><\/html>\n<style id=\"MOBILE-BROCHURE-FIX\">\n@media(max-width:640px){\n .cd-page .brochure{\n white-space:nowrap !important;\n width:100% !important;\n box-sizing:border-box !important;\n padding:13px 14px !important;\n font-size:11px !important;\n letter-spacing:.10em !important;\n line-height:1.2 !important;\n }\n}\n<\/style>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Counterparty Due Diligence | SwissMed Investments COUNTERPARTYDUE DILIGENCE EXACT SCOPE OF REVIEW Evidence-Based ReviewCorporate StandingCommercial RepresentationRisk Indicators COUNTERPARTY DUE DILIGENCE PDF \u2192 EXACT SCOPE OF REVIEW Our Counterparty Due Diligence is a structured, evidence-based review of the identity, corporate standing, commercial representation and relevant risk indicators associated with a prospective supplier, seller, trading entity or […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"full-width-container","site-content-style":"unboxed","site-sidebar-style":"unboxed","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"enabled","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-3423","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=\/wp\/v2\/pages\/3423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3423"}],"version-history":[{"count":37,"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=\/wp\/v2\/pages\/3423\/revisions"}],"predecessor-version":[{"id":3546,"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=\/wp\/v2\/pages\/3423\/revisions\/3546"}],"wp:attachment":[{"href":"https:\/\/swissmedinvestments.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}